-
WST-8 Glucose Uptake Assay Kit for Hepatic Models
2026-08-12
Connect hepatic insulin-resistance phenotypes to a practical, non-radioactive glucose uptake readout in hepatocytes and other cell models. This workflow shows how the WST-8 Glucose Uptake Assay Kit can complement autophagy, lipid-accumulation, and genetic-interaction experiments inspired by the Galectin-1–FIP200 axis.
-
5-hme-dCTP for DNA Hydroxymethylation Assays
2026-08-11
5-hme-dCTP enables controlled production of 5hmC-containing DNA for polymerase screening, assay calibration, and epigenetic method development. Its strongest use is as a defined modified-nucleotide substrate that complements, rather than replaces, genome-wide hydroxymethylation mapping in plant stress studies.
-
5-hme-dCTP for 5hmC Assay Workflows
2026-08-11
5-hme-dCTP provides a practical substrate for testing DNA polymerase compatibility, building hydroxymethylated DNA controls, and strengthening epigenetic assay validation. Its greatest value is upstream of interpretation: it helps researchers separate chemistry and workflow limitations from genuine 5hmC biology in plant stress and gene regulation studies.
-
Palonosetron: Selectivity, PK, and CINV
2026-08-10
The reference study presents palonosetron hydrochloride as a highly selective 5-HT3 receptor antagonist with unusually strong receptor affinity, sustained antiemetic activity, and an approximately 40-hour elimination half-life. Its randomized clinical evidence showed noninferior control of acute chemotherapy-related nausea and vomiting and superior control of delayed symptoms versus granisetron, supporting a longer-acting approach to supportive cancer care.
-
Digoxin B7684 for Reliable Cell Assays
2026-08-09
Learn how Digoxin (SKU B7684) can improve the interpretation and reproducibility of cell viability, proliferation, and chikungunya virus assays through mechanism-aware controls, solvent management, and cell-type-specific dosing. The article provides practical guidance for selecting and handling a Na+/K+ ATPase pump inhibitor in biomedical workflows.
-
PFHxS Disrupts Zebrafish Lipid Homeostasis via PPARα
2026-08-08
The 2024 Environmental Science & Technology study shows that environmentally detected PFHxS concentrations disrupt lipid homeostasis in zebrafish larvae and implicates PPARα activation as a molecular initiating event. By integrating lipidomics, transcriptomics, molecular simulation, and antagonist coexposure, the work connects PFHxS exposure with changes in multiple lipid classes and downstream metabolic pathways.
-
Olive Biophenols and Alzheimer’s Pathology: Study Insights
2026-08-07
The reference study connects direct inhibition of Aβ42 aggregation with protection of SH-SY5Y neuroblastoma cells and reduced plaque deposition in APPswe/PS1dE9 mice. Its principal contribution is a staged evaluation of olive biophenols, identifying oleuropein, verbascoside, and rutin as leading anti-amyloidogenic candidates while also highlighting unresolved questions about mechanism, bioavailability, and blood–brain barrier penetration.
-
N-MYC/eIF4G1 Axis Drives Survival in inv(16) AML: New Insigh
2026-08-07
This study reveals that N-MYC is overexpressed in inv(16) acute myeloid leukemia (AML) and directly regulates cell survival via eIF4G1, a previously unrecognized oncogenic effector in this context. These findings illuminate a novel transcriptional program in leukemogenesis and offer a strong rationale for targeting the N-MYC/eIF4G1 axis in future therapeutic strategies.
-
Alosetron: 5-HT3 Receptor Antagonist for Intestinal Polarity
2026-08-06
Alosetron from APExBIO empowers precision dissection of 5-HT3 receptor signaling in gut epithelial polarity and stem cell fate models. This guide details optimized workflows, troubleshooting strategies, and novel assay designs inspired by recent CDC42-YAP-mTOR pathway discoveries.
-
Trichostatin A (TSA): Protocols and Innovations in Epigeneti
2026-08-06
Trichostatin A (TSA) is a gold-standard HDAC inhibitor enabling advanced epigenetic modulation in cancer and regenerative research. This guide details applied workflows, troubleshooting solutions, and new experimental frontiers inspired by nerve-mediated HDAC regulation in regeneration. Discover how APExBIO's TSA empowers reproducible, high-impact results.
-
Dabigatran Etexilate: Transforming Thrombin Inhibition in Re
2026-08-05
This thought-leadership article explores how dabigatran etexilate, a potent oral direct thrombin inhibitor, is reshaping translational anticoagulant research. We combine mechanistic insight with pragmatic guidance, referencing clinical evidence and APExBIO's high-purity offering to guide protocol optimization and future directions in atrial fibrillation and stroke studies.
-
Berberine Prevents AF via SIRT6-AMPK-Mediated NLRP3 Inhibiti
2026-08-05
This study reveals that berberine suppresses atrial fibrosis and atrial fibrillation susceptibility by activating the SIRT6-AMPK pathway and inhibiting NLRP3 inflammasome signaling. These findings clarify a mechanistic link between metabolic and inflammatory pathways in cardiac remodeling, offering a focused target for future anti-arrhythmic research.
-
H2S Deficiency and ER Stress: Mechanisms in Diabetic Cardiom
2026-08-04
This study establishes a mechanistic link between reduced endogenous hydrogen sulfide (H2S) production and elevated endoplasmic reticulum (ER) stress in diabetic cardiomyopathy (DCM). It demonstrates that restoring H2S levels can mitigate myocardial injury by alleviating ER stress, highlighting a novel therapeutic axis for diabetic heart disease.
-
ML385: Applied NRF2 Inhibition for Redox and Cancer Research
2026-08-04
ML385 is a benchmark NRF2 inhibitor enabling precise interrogation of redox signaling and therapeutic resistance in cancer and inflammation models. This guide details experimental workflows, validation strategies, and troubleshooting tips, spotlighting recent translational research that leverages ML385 as a critical tool for dissecting NRF2-dependent biology.
-
ML385 (SKU B8300): Reliable NRF2 Inhibition for Translationa
2026-08-03
This article addresses real-world challenges in cell-based assays, focusing on the reproducible application of ML385 (SKU B8300), a selective NRF2 inhibitor. By integrating scenario-driven Q&A with recent literature and protocol guidance, it empowers researchers to optimize experimental design and data interpretation using ML385 in cancer and oxidative stress models.